Phoenix CourtHuge congratulations to Spore.Bio on their $23M Series A
This isn’t just about scientific discovery — it’s about delivering real-world impact.
Spore.Bio’s groundbreaking, light-powered microbiology testing is transforming safety across industries, delivering insights in minutes instead of days which has the potential to save lives.
Their early successes, including achieving accuracy on par with traditional methods, a partnership with the Pasteur Institute (world leader in microbiology), acquiring a local competitor, and over 200 factories already in scope and waiting to receive Spore’s technology, are undeniable.
We’re thrilled to continue to partner with these incredible Founders @Amine Raji, @Maxime Mistretta, and @Mohamed Tazi and their phenomenal multi-disciplinary team on their game-changing technology and mission which is poised to make a significant impact on food safety and public health globally.
Excited to welcome Raffi, Maud and team Singular to the journey!
A huge win for Europe and the world-leading microbiology community in France!
Related reading
)
19 Oct 2026 — editorialWritten by Phoenix Court
The Three Clock Speeds
At our Annual Showcase 2026, five companies shared experience from building across vastly different paces and timeframes.
)
2 Oct 2026 — editorialWritten by Phoenix Court
$5.5BN+ raised. Reflections from one of our biggest quarters to date
From robotics to cutting edge biocomputing, from outer space to inner creativity: Q3 2026 was our busiest summer in memory.
)
23 Sept 2026
British Business Bank commits £50m to Phoenix Court as NatWest joins M&G and HSBC to back platform investing in Britain's scale-ups
Institutional investors join forces to ensure more of the value created by UK innovation benefits Britain Meaningful multi-year partnership across Phoenix Court’s platform, supporting British technology companies across…
)
22 Sept 2026Written by Saul Klein
Why Britain needs to back Britain
As a serial entrepreneur, operator and investor I’ve noticed that Britain has a habit of talking itself down, even when the evidence tells a different story. Across the…